Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM185PE
TNBC
Luminal
XRP44X
ELK3
MAPK
12269.157
uM
0.01870
0.01625
0.1418 0.2521 4.9999 0.4915
0.6464
0.5397
SUM185PE
TNBC
Luminal
ZM-447439
AURK
AURK
12269.16
uM
29.68990
62.01540
-0.3594 -1.0000 1.4915 0.1898
0.9050
0.6567
SUM190PT
HER2amp
Luminal
Ribavirin
15358.211
uM
inf
inf
1.0036 1.0036 0.0000 -0.0073
-0.0327
1.3504
SUM190PT
HER2amp
Luminal
Torkinib
15358.211
uM
0.12352
0.43018
-0.6414 -0.6618 0.6757 0.6069
0.9927
1.3504
SUM225CWN
HER2amp
Basal A
5-DFUR
TYMS
TYMS
10579.143
uM
368.270
1000.00000
-0.3720 -0.6996 0.8761 0.2790
0.9539
0.7678
SUM225CWN
HER2amp
Basal A
5-DFUR
TYMS
TYMS
12098.143
uM
184.02540
1000.00000
-0.3284 -0.8209 0.5739 0.3134
0.9890
0.9820
SUM225CWN
HER2amp
Basal A
Afatinib
EGFR/HER2
ErbB
12098.158
uM
0.01127
0.11444
-0.9807 -0.9096 0.4472 0.9166
0.9438
1.1438
SUM225CWN
HER2amp
Basal A
AG1024
IGF1R
RTK
7533.066
uM
6.97750
6.8250
0.0527 0.0523 5.0000 0.1191
0.9671
0.8676
SUM225CWN
HER2amp
Basal A
AG1024
IGF1R
RTK
7534.066
uM
7.97910
4.70390
0.3051 0.2458 1.2803 0.1265
0.9847
1.0191
SUM225CWN
HER2amp
Basal A
AS-252424
PI3K
PI3K
10579.141
uM
0.94552
29.31350
-0.0851 -1.0000 0.3199 0.4084
0.8362
0.8894
SUM225CWN
HER2amp
Basal A
AS-252424
PI3K
PI3K
12098.158
uM
9.92050
169.70510
0.1308 -1.0000 0.3869 0.2087
0.9233
1.1438
SUM225CWN
HER2amp
Basal A
Baicalein
Lipoxygenase
Metabolism
10579.072
uM
38.17410
40.38090
-0.1613 -0.1622 4.9999 0.1497
0.9502
0.9654
SUM225CWN
HER2amp
Basal A
Bortezomib
Proteasome
Proteasome
14803.203
uM
0.00522
0.00940
-0.4349 -0.3483 0.8989 0.9027
0.9647
1.4290
SUM225CWN
HER2amp
Basal A
Bortezomib
Proteasome
Proteasome
14803.203
uM
0.00522
0.00940
-0.4349 -0.3483 0.8989 0.9027
0.9647
1.4290
SUM225CWN
HER2amp
Basal A
Bortezomib
Proteasome
Proteasome
7534.074
uM
0.03580
0.07687
-0.7017 -0.6263 1.0626 0.9468
0.9861
1.1026
SUM225CWN
HER2amp
Basal A
Bortezomib
Proteasome
Proteasome
7534.074
uM
0.03580
0.07687
-0.7017 -0.6263 1.0626 0.9468
0.9861
1.1026
SUM225CWN
HER2amp
Basal A
Bortezomib
Proteasome
Proteasome
7533.074
uM
0.06657
0.12544
-0.6770 -0.6155 1.2665 0.8771
0.9932
1.0648
SUM225CWN
HER2amp
Basal A
Bortezomib
Proteasome
Proteasome
7533.074
uM
0.06657
0.12544
-0.6770 -0.6155 1.2665 0.8771
0.9932
1.0648
SUM225CWN
HER2amp
Basal A
Bortezomib
Proteasome
Proteasome
15335.203
uM
0.01161
0.03143
-0.9577 -0.9350 1.0585 1.1505
0.9995
0.8170
SUM225CWN
HER2amp
Basal A
Bortezomib
Proteasome
Proteasome
15335.203
uM
0.01161
0.03143
-0.9577 -0.9350 1.0585 1.1505
0.9995
0.8170
SUM225CWN
HER2amp
Basal A
Bosutinib
Src
nRTK
10579.145
uM
0.91723
7.74360
-0.0649 -0.5659 0.3548 0.4411
0.8943
1.0664
SUM225CWN
HER2amp
Basal A
Bosutinib
Src
nRTK
12098.145
uM
1.55050
3.34380
-0.4423 -0.5615 0.9796 0.4708
0.9506
0.9769
SUM225CWN
HER2amp
Basal A
Celecoxib
COX2
COX
10579.136
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6876
SUM225CWN
HER2amp
Basal A
Chk2 inhibitor II
CHK2
CHK
10579.14
uM
inf
inf
0.6784 0.6784 0.0000 0.0743
0.2850
0.9303
SUM225CWN
HER2amp
Basal A
Dactolisib
PI3K
PI3K
12098.155
uM
inf
inf
0.5885 0.5885 0.0000 0.3880
0.4982
1.0503